IS7728A - Aðferð til að framleiða kalsíumsalt rósuvastatíns - Google Patents
Aðferð til að framleiða kalsíumsalt rósuvastatínsInfo
- Publication number
- IS7728A IS7728A IS7728A IS7728A IS7728A IS 7728 A IS7728 A IS 7728A IS 7728 A IS7728 A IS 7728A IS 7728 A IS7728 A IS 7728A IS 7728 A IS7728 A IS 7728A
- Authority
- IS
- Iceland
- Prior art keywords
- preparation
- calcium salt
- rosuvastatin calcium
- rosuvastatin
- salt
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0218781.3A GB0218781D0 (en) | 2002-08-13 | 2002-08-13 | Chemical process |
PCT/GB2003/003463 WO2004014872A1 (en) | 2002-08-13 | 2003-08-07 | Process for preparing the calcium salt of rosuvastatin |
Publications (1)
Publication Number | Publication Date |
---|---|
IS7728A true IS7728A (is) | 2005-03-08 |
Family
ID=9942204
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS7728A IS7728A (is) | 2002-08-13 | 2005-03-08 | Aðferð til að framleiða kalsíumsalt rósuvastatíns |
Country Status (30)
Country | Link |
---|---|
US (2) | US7511140B2 (is) |
EP (1) | EP1539711B1 (is) |
JP (1) | JP4588446B2 (is) |
KR (1) | KR101325827B1 (is) |
CN (1) | CN100361979C (is) |
AR (1) | AR040868A1 (is) |
AT (1) | ATE501125T1 (is) |
AU (1) | AU2003251369B2 (is) |
BR (1) | BR0313394A (is) |
CA (1) | CA2495296C (is) |
CY (1) | CY1112412T1 (is) |
DE (1) | DE60336326D1 (is) |
DK (1) | DK1539711T3 (is) |
ES (1) | ES2361009T3 (is) |
GB (1) | GB0218781D0 (is) |
HK (1) | HK1082735A1 (is) |
IL (1) | IL166626A (is) |
IS (1) | IS7728A (is) |
MX (1) | MXPA05001582A (is) |
MY (1) | MY135301A (is) |
NO (1) | NO329439B1 (is) |
NZ (1) | NZ538070A (is) |
PL (1) | PL375296A1 (is) |
PT (1) | PT1539711E (is) |
RU (1) | RU2326871C2 (is) |
SI (1) | SI1539711T1 (is) |
TW (1) | TWI316058B (is) |
UA (1) | UA83805C2 (is) |
WO (1) | WO2004014872A1 (is) |
ZA (1) | ZA200500745B (is) |
Families Citing this family (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6733780B1 (en) | 1999-10-19 | 2004-05-11 | Genzyme Corporation | Direct compression polymer tablet core |
GB0003305D0 (en) | 2000-02-15 | 2000-04-05 | Zeneca Ltd | Pyrimidine derivatives |
GB0011120D0 (en) | 2000-05-09 | 2000-06-28 | Avecia Ltd | Process |
NL1015744C2 (nl) | 2000-07-19 | 2002-01-22 | Dsm Nv | Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten. |
AR034772A1 (es) | 2001-07-13 | 2004-03-17 | Astrazeneca Uk Ltd | Preparacion de los compuestos de aminopirimidina |
EP1323717A1 (en) | 2001-12-27 | 2003-07-02 | Dsm N.V. | Process for the preparation of 2-(6-Substituted-1,3-Dioxane-4-yL) acetic acid derivatives |
EP1375493A1 (en) | 2002-06-17 | 2004-01-02 | Dsm N.V. | Process for the preparation of an dioxane acetic acid ester |
GB0218781D0 (en) | 2002-08-13 | 2002-09-18 | Astrazeneca Ab | Chemical process |
JP4579821B2 (ja) | 2002-12-16 | 2010-11-10 | アストラゼネカ・ユーケイ・リミテッド | ピリミジン化合物を製造するための方法 |
GB0312896D0 (en) * | 2003-06-05 | 2003-07-09 | Astrazeneca Ab | Chemical process |
WO2005023778A2 (en) * | 2003-08-28 | 2005-03-17 | Teva Pharmaceutical Industries Ltd. | Process for preparation of rosuvastatin calcium |
UY28501A1 (es) * | 2003-09-10 | 2005-04-29 | Astrazeneca Uk Ltd | Compuestos químicos |
GB0321827D0 (en) * | 2003-09-18 | 2003-10-15 | Astrazeneca Uk Ltd | Chemical compounds |
GB0324791D0 (en) * | 2003-10-24 | 2003-11-26 | Astrazeneca Ab | Chemical process |
TW200526596A (en) | 2003-11-24 | 2005-08-16 | Teva Pharma | Crystalline ammonium salts of rosuvastatin |
CA2546894C (en) | 2003-12-02 | 2009-09-08 | Teva Pharmaceutical Industries Ltd. | Reference standard for characterization of rosuvastatin |
EP1737828A1 (en) * | 2004-01-19 | 2007-01-03 | Ranbaxy Laboratories Limited | Amorphous magnesium salts of rosuvastatin |
US7241800B2 (en) | 2004-03-17 | 2007-07-10 | Mai De Ltd. | Anhydrous amorphous form of fluvastatin sodium |
CA2573857A1 (en) | 2004-07-13 | 2006-02-16 | Teva Pharmaceutical Industries Ltd. | A process for the preparation of rosuvastatin involving a tempo-mediated oxidation step |
WO2006035277A2 (en) * | 2004-09-27 | 2006-04-06 | Ranbaxy Laboratories Limited | Novel processes for preparing amorphous rosuvastatin calcium and a novel polymorphic form of rosuvastatin sodium |
US7985418B2 (en) | 2004-11-01 | 2011-07-26 | Genzyme Corporation | Aliphatic amine polymer salts for tableting |
CA2591053C (en) | 2004-12-23 | 2011-03-15 | Zhejiang Hisun Pharma. Co., Ltd | Pyrimidinone compounds and preparation and use thereof |
GB0428328D0 (en) * | 2004-12-24 | 2005-02-02 | Astrazeneca Uk Ltd | Chemical process |
CA2594692A1 (en) * | 2005-01-31 | 2006-08-03 | Ciba Specialty Chemicals Holding Inc. | Crystalline forms of rosuvastatin calcium salt |
TWI345562B (en) | 2005-02-22 | 2011-07-21 | Teva Pharma | Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the preparation thereof |
CA2612587C (en) * | 2005-06-24 | 2013-02-19 | Lek Pharmaceuticals D.D. | Process for preparing amorphous rosuvastatin calcium free of impurities |
PL1915349T5 (pl) | 2005-06-24 | 2019-02-28 | Lek Pharmaceuticals D.D. | Sposób wytwarzania czystej bezpostaciowej rozuwastatyny wapniowej |
GB0514078D0 (en) * | 2005-07-08 | 2005-08-17 | Astrazeneca Uk Ltd | Chemical process |
MX2008001597A (es) * | 2005-08-04 | 2008-04-04 | Transform Pharmaceuticals Inc | Formulaciones novedosas que comprenden fenofibrato y una estatina y metodos relacionados de tratamiento. |
WO2007022488A2 (en) | 2005-08-16 | 2007-02-22 | Teva Pharmaceutical Industries Ltd. | Crystalline rosuvastatin intermediate |
EP1919880A2 (en) | 2005-08-16 | 2008-05-14 | Teva Pharmaceutical Industries Ltd. | Rosuvastatin calcium with a low salt by-product content |
HUE026628T2 (en) | 2005-09-15 | 2016-06-28 | Genzyme Corp | Pouches for amine polymers |
WO2007125547A2 (en) | 2006-05-03 | 2007-11-08 | Manne Satyanarayana Reddy | Novel process for statins and its pharmaceutically acceptable salts thereof |
HUE028475T2 (en) | 2006-10-09 | 2016-12-28 | Msn Laboratories Private Ltd | A novel process for the preparation of statins and their pharmaceutically acceptable salts |
EP2079712A2 (en) * | 2006-10-31 | 2009-07-22 | Aurobindo Pharma Limited | An improved process for preparing rosuvastatin calcium |
TW200831469A (en) * | 2006-12-01 | 2008-08-01 | Astrazeneca Uk Ltd | Chemical process |
US8212034B2 (en) | 2006-12-13 | 2012-07-03 | Aurobindo Pharma Ltd. | Process for preparing rosuvastatin calcium |
ES2385623T3 (es) * | 2007-02-08 | 2012-07-27 | Aurobindo Pharma Limited | Un procedimiento mejorado para la preparación de rosuvastatina cálcica |
WO2009009153A1 (en) * | 2007-07-12 | 2009-01-15 | Teva Pharmaceutical Industries Ltd. | Purification of rosuvastatin intermediate by thin film evaporation and chemical method |
HU230981B1 (hu) * | 2007-10-12 | 2019-08-28 | Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság | Eljárás rosuvastatin só előállítására |
HU230637B1 (hu) * | 2007-10-12 | 2017-05-29 | Egis Gyógyszergyár Nyilvánosan Működő Részvénytársaság | Eljárás rosuvastatin intermedierek előállítására |
EP2298745B1 (en) | 2008-05-27 | 2014-09-03 | Changzhou Pharmaceutical Factory | Preparation method of rosuvastatin calcium and its intermediates |
WO2010035284A2 (en) * | 2008-09-26 | 2010-04-01 | Matrix Laboratories Ltd | An improved process for the preparation of rosuvastatin calcium |
WO2010038124A1 (en) * | 2008-09-30 | 2010-04-08 | Aurobindo Pharma Limited | An improved process for preparing pyrimidine propenaldehyde |
WO2010082072A1 (en) | 2009-01-15 | 2010-07-22 | Egis Gyógyszergyár | Process for the preparation of rosuvastatin salts |
EP2387561A4 (en) | 2009-01-19 | 2012-07-25 | Msn Lab Ltd | IMPROVED PROCESS FOR THE PREPARATION OF HIGH-PURITY (3R, 5S) -7-β-CYCLOPROPYL-4- (4-FLUOROPHENYL) QUINOLIN-3-YL-3,5-DIHYDROXY-6 (E) -HEPTENOIC ACID, INCLUDING ITS PHARMACEUTICALLY ACCEPTABLE SALTS |
EP2526099B1 (en) | 2010-01-18 | 2016-03-30 | MSN Laboratories Limited | Improved process for the preparation of amide intermediates and their use thereof |
AU2011243948B2 (en) | 2010-04-23 | 2014-07-17 | Sun Pharmaceutical Industries Limited | Novel intermediates for the preparation of HMG-CoA reductase inhibitors |
HU230987B1 (hu) | 2010-11-29 | 2019-08-28 | Egis Gyógyszergyár Nyrt. | Eljárás nagy tisztaságú gyógyszeripari intermedierek előállítására |
MX2015013696A (es) * | 2013-03-29 | 2016-02-26 | Dsm Sinochem Pharm Nl Bv | Sales de amina de pitavastatina y rosuvastatina. |
TWM477638U (zh) * | 2013-12-12 | 2014-05-01 | 三緯國際立體列印科技股份有限公司 | 加熱平台與立體列印裝置 |
KR102139346B1 (ko) | 2017-01-23 | 2020-07-29 | 동화약품주식회사 | HMG-CoA 환원효소 억제제 및 클로피도그렐을 포함하는 복합제제 |
CR20210669A (es) | 2019-05-27 | 2022-05-05 | Immatics Us Inc | Vectores víricos y uso de los mismos en terapias celulares adoptivas |
DE102020111571A1 (de) | 2020-03-11 | 2021-09-16 | Immatics US, Inc. | Wpre-mutantenkonstrukte, zusammensetzungen und zugehörige verfahren |
TW202227616A (zh) | 2020-08-21 | 2022-07-16 | 美商英麥提克斯股份有限公司 | 分離cd8+選擇t細胞的方法 |
SI26268A (sl) | 2021-11-18 | 2023-05-31 | Zupet Rok | Postopek za pripravo hidratirane oblike perindopril l-arginina |
Family Cites Families (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US663641A (en) * | 1900-10-11 | 1900-12-11 | Charles A Ruebekam | Burial-casket. |
US4645858A (en) | 1982-03-22 | 1987-02-24 | G. D. Searle & Co. | Pentanedioic acid derivatives |
DE3741509A1 (de) | 1987-12-08 | 1989-06-22 | Hoechst Ag | Verfahren zur herstellung optisch aktiver 3-desmethylmevalonsaeurederivate sowie zwischenprodukte |
KR900701778A (ko) | 1988-10-06 | 1990-12-04 | 예안 크라머, 한스 루돌프 하우스 | 피리미디닐- 치환된 하이드록시산, 락톤 및 에스테르, 및 이를 함유하는 약학적 조성물 |
US5026698A (en) | 1988-11-02 | 1991-06-25 | Nissan Chemical Industries, Ltd. | Thienopyridine type mevalonolactones |
JP2648897B2 (ja) | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
WO1993008823A1 (en) | 1991-11-06 | 1993-05-13 | Tanabe Seiyaku Co., Ltd. | Guanidinyl and related cell adhesion modulation compounds |
US5278313A (en) | 1992-03-27 | 1994-01-11 | E. R. Squibb & Sons, Inc. | Process for the preparation of 1,3-dioxane derivatives useful in the preparation of HMG-COA reductase inhibitors |
SG44830A1 (en) | 1992-07-02 | 1997-12-19 | Hoechst Ag | Process for preparing tert-butyl 93R,5S) -6 Hydroxy-3,5-O-Isopropylidene-3, 5-Dihydroxyhexanoate |
ES2167587T3 (es) | 1995-07-17 | 2002-05-16 | Warner Lambert Co | Forma cristalina de la sal hemicalcica del acido (r-(r*,r*))-2-(4-fluorofenil)-beta,delta-dihidroxi-5-(1-metiletil)-3-fenil-4-((fenilamino)carbonil)-1h-pirrol-1-heptanoico (atorvastatina). |
FR2741620B1 (fr) | 1995-11-28 | 1997-12-26 | Oreal | Procede de preparation de composes a groupement beta-hydroxy -delta-lactone analogues de la (+) compactine et de la (+) mevinoline |
US6278001B1 (en) | 1995-11-28 | 2001-08-21 | L'oréal | Method for preparing (+) compactin and (+) mevinolin analog compounds having a β-hydroxy-δ-lactone grouping |
ATE234282T1 (de) | 1996-06-24 | 2003-03-15 | Novartis Pharma Gmbh | Polymorphe verbindungen |
CZ299522B6 (cs) | 1998-12-10 | 2008-08-27 | Kaneka Corporation | Zpusob výroby diolu obsahujícího laktonovou skupinu |
GB9900339D0 (en) | 1999-01-09 | 1999-02-24 | Zeneca Ltd | Chemical compounds |
GB9903472D0 (en) | 1999-02-17 | 1999-04-07 | Zeneca Ltd | Chemical process |
ES2251392T3 (es) * | 1999-07-13 | 2006-05-01 | Lonza Ag | Procedimiento para preparar 2-amino-4-(4-fluorofenil)-6-alquilpirimidina-5-carboxilatos. |
AU7717500A (en) | 1999-09-30 | 2001-04-30 | Merck & Co., Inc. | Anti-hypercholesterolemic drug combination |
YU35802A (sh) | 1999-11-17 | 2005-07-19 | Teva Pharmaceutical Industries Ltd. | Polimorfni oblik atorvastatin kalcijuma |
GB0001621D0 (en) | 2000-01-26 | 2000-03-15 | Astrazeneca Ab | Pharmaceutical compositions |
GB0003305D0 (en) | 2000-02-15 | 2000-04-05 | Zeneca Ltd | Pyrimidine derivatives |
WO2001072706A1 (en) | 2000-03-28 | 2001-10-04 | Biocon India Limited | Synthesis of [r-(r*,r*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin) |
GB0011120D0 (en) * | 2000-05-09 | 2000-06-28 | Avecia Ltd | Process |
GB0011163D0 (en) | 2000-05-10 | 2000-06-28 | Astrazeneca Ab | Chemical compound |
NL1015744C2 (nl) * | 2000-07-19 | 2002-01-22 | Dsm Nv | Werkwijze voor de bereiding van 2-(6-gesubstitueerde-1,3-dioxan-4-yl) azijnzuurderivaten. |
AU2002211462A1 (en) | 2000-10-05 | 2002-04-22 | Teva Gyogyszergyar Reszvenytarsasag | Pravastatin sodium substantially free of pravastatin lactone and epi-pravastatin, and compositions containing same |
US6777552B2 (en) | 2001-08-16 | 2004-08-17 | Teva Pharmaceutical Industries, Ltd. | Processes for preparing calcium salt forms of statins |
ES2313999T3 (es) | 2000-11-16 | 2009-03-16 | Teva Pharmaceutical Industries Ltd. | Hidrolisis de esteres del acido (r(r*,r*))-2-(4-fluorofenil)-beta, delta-dihidroxi-5-(1-metiletil)-3-fenil-4-((fenilamino)carbonil)-1h-pirrol-1-heptanoico con hidroxido calcico. |
IL156055A0 (en) | 2000-11-30 | 2003-12-23 | Teva Pharma | Novel crystal forms of atorvastatin hemi calcium and processes for their preparation as well as novel processes for preparing other forms |
NL1017548C2 (nl) | 2001-03-09 | 2002-09-10 | Synthon Bv | Een lactonisatie proces. |
IN190564B (is) | 2001-04-11 | 2003-08-09 | Cadila Heathcare Ltd | |
CA2449813A1 (en) | 2001-06-06 | 2002-12-12 | Bristol-Myers Squibb Company | Process for preparing chiral diol sulfones and dihydroxy acid hmg coa reductase inhibitors |
AR034772A1 (es) * | 2001-07-13 | 2004-03-17 | Astrazeneca Uk Ltd | Preparacion de los compuestos de aminopirimidina |
PL370407A1 (en) | 2001-08-16 | 2005-05-30 | Teva Pharmaceutical Industries Ltd. | Processes for preparing calcium salt forms of statins |
EP1423365A1 (en) | 2001-08-22 | 2004-06-02 | Ciba Specialty Chemicals Holding Inc. | Process for the preparation of indole derivatives |
JP2005512516A (ja) | 2001-09-24 | 2005-05-12 | メルク エンド カムパニー インコーポレーテッド | スタチン薬物の組合せのスクリーニング方法および選択方法 |
EP1323717A1 (en) * | 2001-12-27 | 2003-07-02 | Dsm N.V. | Process for the preparation of 2-(6-Substituted-1,3-Dioxane-4-yL) acetic acid derivatives |
KR100511533B1 (ko) | 2002-04-09 | 2005-08-31 | 임광민 | 키랄 중간체, 그의 제조방법 및 그를 이용한 HMG-CoA환원저해제의 제조방법 |
EA200401533A1 (ru) | 2002-05-21 | 2005-06-30 | Ранбакси Лабораторис Лимитед | Способ получения росувастатина |
EP1375493A1 (en) | 2002-06-17 | 2004-01-02 | Dsm N.V. | Process for the preparation of an dioxane acetic acid ester |
GB0218781D0 (en) * | 2002-08-13 | 2002-09-18 | Astrazeneca Ab | Chemical process |
AU2002348881A1 (en) | 2002-12-10 | 2004-06-30 | Ranbaxy Laboratories Limited | Process for the preparation of rosuvastatin |
JP4579821B2 (ja) * | 2002-12-16 | 2010-11-10 | アストラゼネカ・ユーケイ・リミテッド | ピリミジン化合物を製造するための方法 |
CA2520740C (en) | 2003-04-11 | 2012-06-05 | Lek Pharmaceuticals D.D. | Process for the preparation of amorphous calcium salt of atorvastatin |
WO2004103977A2 (en) | 2003-05-21 | 2004-12-02 | Ciba Specialty Chemicals Holding Inc. | Process for the preparation of pyrimidine derivatives |
GB0312896D0 (en) * | 2003-06-05 | 2003-07-09 | Astrazeneca Ab | Chemical process |
WO2005005384A1 (en) | 2003-07-15 | 2005-01-20 | Eos Eczacibasi Ozgun Kimyasal Urunler Sanyi Ve Ticaret A.S. | Process for the preparation of amortphous atorvastatin calcium without interconversion of any crystalline form |
WO2005023778A2 (en) | 2003-08-28 | 2005-03-17 | Teva Pharmaceutical Industries Ltd. | Process for preparation of rosuvastatin calcium |
UY28501A1 (es) | 2003-09-10 | 2005-04-29 | Astrazeneca Uk Ltd | Compuestos químicos |
GB0321827D0 (en) * | 2003-09-18 | 2003-10-15 | Astrazeneca Uk Ltd | Chemical compounds |
GB0322552D0 (en) | 2003-09-26 | 2003-10-29 | Astrazeneca Uk Ltd | Therapeutic treatment |
EP1678148A1 (en) | 2003-10-22 | 2006-07-12 | Ranbaxy Laboratories Limited | Process for the preparation of amorphous rosuvastatin calcium |
GB0324791D0 (en) | 2003-10-24 | 2003-11-26 | Astrazeneca Ab | Chemical process |
DE10352659B4 (de) | 2003-11-11 | 2007-09-13 | Ratiopharm Gmbh | Verfahren zur Herstellung von Statinen und Tetrahydropyranonderivate zur Verwendung in dem Verfahren |
WO2005077916A1 (en) | 2004-01-19 | 2005-08-25 | Ranbaxy Laboratories Limited | Salts of hmg-coa reductase inhibitors and use thereof |
US7028631B2 (en) * | 2003-11-24 | 2006-04-18 | The Boeing Company | Gliding submersible transport system |
TW200526596A (en) | 2003-11-24 | 2005-08-16 | Teva Pharma | Crystalline ammonium salts of rosuvastatin |
CA2546894C (en) | 2003-12-02 | 2009-09-08 | Teva Pharmaceutical Industries Ltd. | Reference standard for characterization of rosuvastatin |
WO2005054207A1 (en) | 2003-12-04 | 2005-06-16 | Glenmark Pharmaceuticals Limited | Process for the preparation of pyrimidine derivatives |
WO2005063728A2 (en) | 2003-12-24 | 2005-07-14 | Teva Pharmaceutical Industries Ltd. | Process for preparation of statins with high syn to anti ratio |
CZ200486A3 (cs) | 2004-01-16 | 2005-08-17 | Zentiva, A.S. | Způsob výroby hemivápenaté soli (E)-7-[4-(4-fluorfenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxy-6-heptenové kyseliny |
EP1737828A1 (en) | 2004-01-19 | 2007-01-03 | Ranbaxy Laboratories Limited | Amorphous magnesium salts of rosuvastatin |
US7241800B2 (en) | 2004-03-17 | 2007-07-10 | Mai De Ltd. | Anhydrous amorphous form of fluvastatin sodium |
GB0406757D0 (en) | 2004-03-26 | 2004-04-28 | Avecia Ltd | Process and compounds |
US7161004B2 (en) | 2004-06-21 | 2007-01-09 | Dr. Reddy's Laboratories Limited | Processes to produce intermediates for rosuvastatin |
CA2573857A1 (en) | 2004-07-13 | 2006-02-16 | Teva Pharmaceutical Industries Ltd. | A process for the preparation of rosuvastatin involving a tempo-mediated oxidation step |
WO2006035277A2 (en) | 2004-09-27 | 2006-04-06 | Ranbaxy Laboratories Limited | Novel processes for preparing amorphous rosuvastatin calcium and a novel polymorphic form of rosuvastatin sodium |
GB0428328D0 (en) | 2004-12-24 | 2005-02-02 | Astrazeneca Uk Ltd | Chemical process |
CA2594692A1 (en) | 2005-01-31 | 2006-08-03 | Ciba Specialty Chemicals Holding Inc. | Crystalline forms of rosuvastatin calcium salt |
CA2498978A1 (en) | 2005-02-28 | 2006-08-28 | Apotex Pharmachem Inc. | An improved process for the preparation of atorvastatin and intermediates |
GB0514078D0 (en) * | 2005-07-08 | 2005-08-17 | Astrazeneca Uk Ltd | Chemical process |
TW200831469A (en) * | 2006-12-01 | 2008-08-01 | Astrazeneca Uk Ltd | Chemical process |
-
2002
- 2002-08-13 GB GBGB0218781.3A patent/GB0218781D0/en not_active Ceased
-
2003
- 2003-07-08 UA UAA200500711A patent/UA83805C2/uk unknown
- 2003-08-07 PT PT03784274T patent/PT1539711E/pt unknown
- 2003-08-07 EP EP03784274A patent/EP1539711B1/en not_active Revoked
- 2003-08-07 AU AU2003251369A patent/AU2003251369B2/en not_active Expired
- 2003-08-07 PL PL03375296A patent/PL375296A1/xx unknown
- 2003-08-07 ES ES03784274T patent/ES2361009T3/es not_active Expired - Lifetime
- 2003-08-07 AT AT03784274T patent/ATE501125T1/de active
- 2003-08-07 SI SI200331993T patent/SI1539711T1/sl unknown
- 2003-08-07 TW TW092121663A patent/TWI316058B/zh not_active IP Right Cessation
- 2003-08-07 MX MXPA05001582A patent/MXPA05001582A/es active IP Right Grant
- 2003-08-07 KR KR1020057002408A patent/KR101325827B1/ko active IP Right Grant
- 2003-08-07 US US10/524,235 patent/US7511140B2/en not_active Expired - Lifetime
- 2003-08-07 JP JP2004527041A patent/JP4588446B2/ja not_active Expired - Lifetime
- 2003-08-07 BR BR0313394-0A patent/BR0313394A/pt not_active IP Right Cessation
- 2003-08-07 WO PCT/GB2003/003463 patent/WO2004014872A1/en active Application Filing
- 2003-08-07 RU RU2005102391/04A patent/RU2326871C2/ru active
- 2003-08-07 NZ NZ538070A patent/NZ538070A/en not_active IP Right Cessation
- 2003-08-07 DE DE60336326T patent/DE60336326D1/de not_active Expired - Lifetime
- 2003-08-07 CN CNB038239949A patent/CN100361979C/zh not_active Expired - Lifetime
- 2003-08-07 CA CA2495296A patent/CA2495296C/en not_active Expired - Fee Related
- 2003-08-07 DK DK03784274.7T patent/DK1539711T3/da active
- 2003-08-11 MY MYPI20033048A patent/MY135301A/en unknown
- 2003-08-13 AR AR20030102929A patent/AR040868A1/es unknown
-
2005
- 2005-01-31 NO NO20050542A patent/NO329439B1/no not_active IP Right Cessation
- 2005-02-01 IL IL166626A patent/IL166626A/en unknown
- 2005-03-08 IS IS7728A patent/IS7728A/is unknown
-
2006
- 2006-01-10 ZA ZA200500745A patent/ZA200500745B/en unknown
- 2006-02-27 HK HK06102591A patent/HK1082735A1/xx not_active IP Right Cessation
-
2009
- 2009-02-13 US US12/371,359 patent/US7842807B2/en not_active Expired - Lifetime
-
2011
- 2011-05-09 CY CY20111100442T patent/CY1112412T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS7728A (is) | Aðferð til að framleiða kalsíumsalt rósuvastatíns | |
HK1087405A1 (en) | Improved production of the rosuvastatin calcium salt | |
NO20041082L (no) | Fremgangsmater for fremstilling av kalsiumsaltformer av statiner | |
IL173858A0 (en) | Process for preparation of rosuvastatin calcium | |
HUP0500851A3 (en) | Process for the preparation of rosuvastatin | |
CR8226A (es) | Proceso para la preparacion de 4-amino-3-quinolincarbonitrilos | |
DK1803718T3 (da) | 4-Tetrazolyl-4-phenylpiperidin-derivater til behandling af smerter | |
HK1080477A1 (en) | Process for the preparation of pyrimidine compounds | |
DK1546122T3 (da) | Fremgangsmåde til fremstilling af valsartan | |
NO20044814L (no) | Fremgangsmate for fremstilling av combretastaniner | |
DK1678135T3 (da) | Fremgangsm de til fremstilling af n-amino-substituerede hetorocykliske forbindelser | |
NO20034597L (no) | Fremgangsmate for fremstilling av cantaxantin | |
ITMI20020933A0 (it) | Procedimento per la sintesi di clopidogrel | |
DK1511724T3 (da) | Fremgangsmåde til fremstilling af thioalkylaminderivater | |
ITMI20031994A1 (it) | Procedimento per la preparazione di fludarabina fosfato | |
ITMI20030018A1 (it) | Procedimento per la preparazione di composti mono- | |
DK1497290T3 (da) | Fremgangsmåde til fremstilling af syresalte af gemifloxacin | |
ITMI20030019A1 (it) | Procedimento per la preparazione di composti mono- | |
FR2835839B1 (fr) | Procede de preparation de la 7beta-hydroxy-dehydroepiandrosterone | |
FI20031420A (fi) | Menetelmä uusien 7-substituoitu-9-(substituoitu amino)-6-demetyyli-6-deoksitetrasykliinien valmistamiseksi | |
ITMI20020620A1 (it) | Procedimento per la preparazione di alchil-benzoati per esterificazione di benzoil-fluoruri | |
ITMO20020179A1 (it) | Impianto perfezionato per la preparazione di calcestruzzo | |
ITPD20030178A1 (it) | Procedimento per la preparazione di lastre | |
ITIS20030007A1 (it) | Procedimento per la preparazione di cefalosporine | |
FI20021413A0 (fi) | Menetelmä klooridioksidin valmistamiseksi |